WJPPS Citation

Login

Search

News & Updation

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: FEBRUARY ISSUE PUBLISHED
  • FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

Abstract

MISREYA ARKA: PIONEERING PAIN MANAGEMENT IN UDAVARTINI YONI VYAPAD (SECONDARY DYSMENORRHEA) – A CASE SERIES

Dr. Uthiraleka G.*, Dr. Rajani Kagga

ABSTRACT

Introduction: Secondary Dysmenorrhea, painful menses due to pelvic pathologies like Endometriosis, Adenomyosis, Fibroids, or PCOS, affects 10-25% of reproductive-age women, causing severe cramps, nausea, and incapacity in day-to-day activities. In Ayurveda, it correlates to Udavartini Yoni Vyapad from Vata vitiation, particularly Apana Vayu, due to Vegadharana and Srotorodha, where conventional treatments like NSAIDs offer only palliative relief with side effects. Method: A case series of five women (aged 26-35 years) diagnosed with Secondary Dysmenorrhea with Clinical examination and Ultrasonography at Sri Sri College of Ayurvedic Science OPD, Bengaluru, received Misreya Arka (24 ml BD) for pain management over two menstrual cycles. Outcomes were assessed using Wong Baker Pain Scale, Verbal Multidimensional Scoring and WALIDD scores pre- and post-treatment. Result: Significant pain reduction was noted (Pain scale from 7-10 to 1-7 across cases), with 40-100% improvement in symptoms like nausea, bloating, constipation, and appetite; co-morbidities resolved in most, enhancing quality of life. Discussion and Conclusion: Misreya Arka's Vatanulomana, antispasmodic, and anti-prostaglandin effects via anethole effectively managed Udavartini Yoni Vyapad by normalizing Apana Vayu and clearing Srotorodha, outperforming symptomatic medications without adverse effects.

Keywords: Udavartini Yoni Vyapad, Secondary dysmenorrhea, Misreya Arka, Quality of life.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More